TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
Mar 30, 2018 20:01 pm UTC| Business
REGULATED INFORMATIONPRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - March 30, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG;...
More Than 20 Cerner Executives Earn Board Certification in Health Care Management
Mar 30, 2018 20:01 pm UTC| Business
KANSAS CITY, Mo., March 30, 2018 -- Cerner announced that 21 of its associates recently earned the distinction of board certification in health care management as Fellows of the American College of Healthcare Executives...
Mar 30, 2018 20:00 pm UTC| Business
NEW YORK, March 30, 2018 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who...
Brandywine Homes to Build Gated Community Offering 22 Townhomes in Anaheim, Calif.
Mar 30, 2018 19:55 pm UTC| Business
ANAHEIM, Calif., March 30, 2018 -- Brandywine Homes has acquired 1.29 acres in Southwest Anaheim, Calif., and plans to build Treviso, a gated community offering 22 three-story townhomes. Brandywine expects to break...
Cartesian Files Annual Report on Form 10-K for Fiscal Year 2017
Mar 30, 2018 19:18 pm UTC| Business
OVERLAND PARK, Kan., March 30, 2018 -- Cartesian, Inc. (OTCQB:CRTN), a leading specialist provider of consulting services and managed solutions to leaders in the global communications, digital media and technology...
Mar 30, 2018 19:15 pm UTC| Business
BAYONNE, N.J., March 30, 2018 -- BCB Bancorp, Inc. (the “Company”), Bayonne, NJ (NASDAQ:BCBP), the holding company for BCB Community Bank (the “Bank”), today announced that the deadline for shareholders of IA Bancorp,...
SteadyMed Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 30, 2018 19:15 pm UTC| Business
SAN RAMON, Calif., March 30, 2018 -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral...